Pooled analysis of MagnetisMM studies: Efficacy and safety of elranatamab in patients with relapsed or refractory multiple myeloma (RRMM) previously exposed to B-cell maturation antigen (BCMA)-directed therapies Meeting Abstract
| Authors: | Nooka, A. K.; Lesokhin, A. M.; Mohty, M.; Niesvizky, R.; Maise, C.; Arnulf, A.; Larson, S. M.; Asya, V. Y. N.; Leleu, X.; Karlin, L.; Vesol, D. H.; Bahlis, N. J.; Fernández de Larrea, C.; Raje, N.; Leip, E.; Conte, C.; Elmeliegy, M.; Viqueira, A.; Manier, M. |
| Abstract Title: | Pooled analysis of MagnetisMM studies: Efficacy and safety of elranatamab in patients with relapsed or refractory multiple myeloma (RRMM) previously exposed to B-cell maturation antigen (BCMA)-directed therapies |
| Meeting Title: | 2023 Lymphoma, Leukemia and Myeloma Congress |
| Journal Title: | American Journal of Hematology |
| Volume: | 98 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2023 Oct 18-21 |
| Meeting Location: | New York, NY |
| ISSN: | 0361-8609 |
| Publisher: | John Wiley & Sons, Inc. |
| Date Published: | 2023-10-01 |
| Start Page: | S27 |
| End Page: | S28 |
| Language: | English |
| ACCESSION: | WOS:001098086400044 |
| PROVIDER: | wos |
| DOI: | 10.1002/ajh.27112 |
| Notes: | Meeting Abstract: P-043 -- Source: Wos |
